Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Saxagliptin is a new investigational medication being developed for treatment of type 2
diabetes. This study is designed to evaluate the efficacy and safety in adult Indian patients
with inadequate glycaemic control with diet and exercise.